> IN EVIDENZA

Gastroenterologia
PPI possono causare neoplasie gastriche…. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.Waldum HL, Sørdal Ø, Fossmark R. Scand J Gastroenterol. 2018 May 31:1-4. Recently, two epidemiological studies showed that long-term treatment with proton pump inhibitors (PPIs) increased the risk of gastric cancer. It is well known that hypergastrinemia predisposes to gastric neoplasia in animals as well as man. Read more

> IN EVIDENZA

Epatologia
Tolvaptan utile nell’ascite refrattaria Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis.Tajiri K, Tokimitsu Y, Ito H, Atarashi Y, Kawai K, Minemura M, Yasumura S, Takahara T, Shimizu Y, Sugiyama T. Dig Dis. 2018 May 31:1-8. AIMS:The study aimed to evaluate the effects of tolvaptan treatment on survival of patients with decompensated liver cirrhosis with refractory ascites. Read more

> IN EVIDENZA

Pancreas e vie biliari
Meta-analisi sul pancreas artificiale Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T, Haidich AB, Hovorka R, Tsapas A. BMJ. 2018 Apr 18;361:k1310. OBJECTIVE:To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant outpatients with type 1 diabetes.DESIGN:Systematic review and meta-analysis of randomised... Read more
  • 1
  • 2
  • 3
Articoli

MULTIMEDIA | YOUTUBE

High Quality Res. - Upper Gastroendoscopy
Video Clip an Endoscopy of a Stomach Cancer
Video Endoscopy of Enormous Gastric Leiomyoma
High Resolution Video Endosocpy of a Deep Gastric Ulcer
The Amedeo Prize Winners 2008
Presentazione del portale EBGH.IT

Informazioni aggiuntive